Prostate Cancer - Results from #22560

Abiraterone acetate: Targeting persistent androgen dependence in castration-resistant prostate cancer - Abstract October 3, 2013

Exercise preferences among men with prostate cancer receiving androgen-deprivation therapy - Abstract October 3, 2013

Nomograms to predict late urinary toxicity after prostate cancer radiotherapy - Abstract October 3, 2013

Challenging treatment decision-making in older urologic cancer patients - Abstract October 3, 2013

The influence of expertise of the surgical pathologist to undergrading, upgrading, and understaging of prostate cancer in patients undergoing subsequent radical prostatectomy - Abstract October 3, 2013

Update on positron emission tomography for imaging of prostate cancer - Abstract October 3, 2013

Detection and localization of carcinoma within the prostate using high resolution transrectal gamma imaging (TRGI) of monoclonal antibody directed at prostate specific membrane antigen (PSMA)-Proof of concept and initial imaging results - Abstract October 3, 2013

Preliminary experience with a novel method of three-dimensional co-registration of prostate cancer digital histology and in vivo multiparametric MRI - Abstract October 3, 2013

The role of elective pelvic radiotherapy in clinically node-negative prostate cancer: A systematic review - Abstract October 3, 2013

Pelvic irradiation in prostate cancer: What place for what volumes? - Abstract October 3, 2013

Five-year oncological outcomes of endoscopic extraperitoneal radical prostatectomy (EERPE) for prostate cancer: Results from a medium-volume UK centre - Abstract October 3, 2013

Targeted therapy in the treatment of castration-resistant prostate cancer - Abstract October 3, 2013

Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody J591 in men with metastatic castration-resistant prostate cancer - Abstract October 3, 2013

Laparoscopic radical prostatectomy monotherapy, a more aggressive yet less invasive option, is oncologically effective in selected men with high-risk prostate cancer having only one D'Amico risk factor: Experience from an Asian tertiary referral center - October 3, 2013

Comprehensive analysis of sexual function outcome in prostate cancer patients after robot-assisted radical prostatectomy - Abstract October 3, 2013

Preoperative predictive model for biochemical recurrence in patients with localized prostate cancer treated with radical prostatectomy - Abstract October 3, 2013

Treatable and untreatable forms of recurrent prostate cancer - Abstract October 3, 2013

Anatomic extent of pelvic lymph node dissection: Impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy - Abstract October 3, 2013

Ascertaining cause of death among men in the Prostate Cancer Intervention Versus Observation Trial - Abstract October 2, 2013

Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: Integrated results from three randomized, double-blind studies of denosumab and zoledronic acid - Abstract October 2, 2013

Page 1129 of 1457